Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-A02303741:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF85 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
mRNA | ZNF850 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | ZNF852 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
mRNA | ZNF862 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZNF878 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
mRNA | ZNF891 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | ZNF91 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
mRNA | ZNF92 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | ZNF93 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
mRNA | ZP1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |